baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Soc. Generale Knock-Out iShares N.../ DE000SQ3VT51 /

2024-05-28 8:58:56 AM	Chg.-0.01	Bid5:48:31 PM	Ask5:48:31 PM	Underlying	Strike price	Expiration date	Option type
5.18EUR	-0.19%	5.09 Bid Size: 35,000	- Ask Size: -	-	79.1224 USD	2078-12-31	Call

GlobeNewswire 4:22 PM SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global...

GlobeNewswire 2:30 PM CytoDyn to Host Webcast to Provide Company Update

GlobeNewswire 2:05 PM CARGO Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire 2:05 PM Longeveron® to Attend BIO International Convention 2024

GlobeNewswire 2:00 PM BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study

GlobeNewswire 2:00 PM Aummune’s Poster at ASCO 2024 to Highlight Ongoing Phase 1 Trial for AM003

GlobeNewswire 2:00 PM Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting

GlobeNewswire 2:00 PM CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing

GlobeNewswire 2:00 PM Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin...

GlobeNewswire 2:00 PM HiberCell Announces First Patient Dosed in Phase 1b Clinical Trial, Evaluating HC-7366 in Combinatio...

GlobeNewswire 1:35 PM Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...

GlobeNewswire 1:30 PM Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD

GlobeNewswire 1:30 PM Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD

GlobeNewswire 1:10 PM Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million

GlobeNewswire 1:03 PM Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 a...

GlobeNewswire 1:02 PM Ocugen Set to Join Russell 3000® Index Effective June 28, 2024

GlobeNewswire 1:02 PM Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria

GlobeNewswire 1:00 PM Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management

GlobeNewswire 1:00 PM Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June

GlobeNewswire 12:59 PM Pasithea Therapeutics to Present New Preclinical Data Showing PAS-004 Strongly Inhibits NRAS Cancer ...

GlobeNewswire 12:30 PM Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire 12:30 PM Affimed Announces Annual General Meeting of Shareholders

GlobeNewswire 12:24 PM Urteste has successfully developed a prototype urine-based diagnostic test for detecting brain tumou...

GlobeNewswire 9:00 AM TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024

GlobeNewswire 05-27 Cellectis to Report First Quarter 2024 Financial Results on May 28, 2024

Soc. Generale Knock-Out iShares N.../ DE000SQ3VT51 /

If you wish to receive reply to your feedback, please provide your email address.